Primary hypoparathyroidism as a seizure trigger in type 1 glutaric aciduria

Barath Gr1, Arvinder Wander2, Saransh Gupta3

  • 1General Medicine, All India Institute of Medical Sciences, Bathinda, Punjab, India.

BMJ Case Reports
|October 29, 2025
PubMed

Insights

This case study presents a female infant with seizures, macrocephaly, and developmental delay. Diagnosis revealed hypocalcaemia due to hypoparathyroidism and glutaric aciduria type 1 (GA1), emphasizing metabolic causes of infant seizures.

Area of Science:

  • Pediatric Neurology
  • Clinical Genetics
  • Neonatal Medicine

Background:

  • Infantile seizures can stem from diverse etiologies, including metabolic derangements.
  • Persistent upward gaze and prolonged postictal phases are concerning neurological signs in infants.
  • Macrocephaly and global developmental delay indicate significant underlying pathology.

Purpose of the Study:

  • To report a rare case of infantile seizures associated with concurrent hypoparathyroidism and glutaric aciduria type 1 (GA1).
  • To highlight the importance of investigating metabolic causes in infants presenting with neurological symptoms.
  • To illustrate the diagnostic challenges and management strategies for complex neonatal metabolic disorders.

Main Methods:

  • Clinical presentation and examination findings of a female infant with recurrent seizures.
  • Laboratory investigations including ionised calcium levels and genetic analysis for GA1.
  • Neuroimaging (brain MRI) to assess structural brain abnormalities.

Main Results:

  • Profound hypocalcaemia (0.6 mmol/L) attributed to primary hypoparathyroidism was identified.
  • Brain MRI revealed an acute subdural haematoma with a 'bat-wing' configuration and bilateral diffusion restriction.
  • Genetic analysis confirmed glutaric aciduria type 1 (GA1).

Conclusions:

  • Metabolic disorders, specifically hypocalcaemia secondary to hypoparathyroidism, should be considered in the differential diagnosis of infantile seizures.
  • Concurrent GA1 and hypoparathyroidism presented with severe neurological manifestations including seizures and subdural haematoma.
  • Multidisciplinary management involving metabolic correction, antiepileptic therapy, and dietary adjustments is crucial for stabilizing patients.

Related Concept Videos

Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
884
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
822
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
691
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K